• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN SURGICAL SA OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP; CARDIAC SUTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN SURGICAL SA OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP; CARDIAC SUTURE Back to Search Results
Model Number C3090902
Device Problems Material Integrity Problem (2978); Separation Problem (4043)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/25/2019
Event Type  malfunction  
Manufacturer Narrative
Pma/510k: reported device not marketed in the u.S., however, similar devices or devices that share components, raw materials, process methods or other technological characteristics are registered within the u.S.K133890.If additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported the needle-suture has "bad fiction." the reporter indicated that the oncology surgical department is experiencing bad fiction with the needle and suture.The needle is permanently tearing from the thread.Per one surgeon, this occurred three times during a surgical procedure.It was reported that all optilene from 3/0 to 10/0, breaks at the junction of the thread with the needle; the 10/0 suture detached when removing from packaging.Per reporter, it is not possible to provide the information about every patient separately.
 
Manufacturer Narrative
Investigation: samples received: (b)(4) unopened race packs.Analysis and results: there are no previous complaints of this code-batch.We manufactured and mostly distributed in the market (b)(4) units of this code-batch.There are (b)(4) units in our stock.We have received (b)(4) closed samples for analysis.We have tested the needle attachment strength of closed samples received and the results fulfil the requirements of the european pharmacopoeia (ep): 0.85 kgf in average and 0.53 kgf in minimum (ep requirements: 0.46 kgf in average and 0.23 kgf in minimum) reviewed the batch manufacturing record, this product had a normal process and the results during the process fulfil usp/ep and b.Braun surgical requirements.Final conclusion: although the results of the closed samples received fulfil the specifications of european pharmacopoeia/ b.Braun surgical specifications, we take note of this incidence in order to assess if new or additional actions are needed.Actions on product distributed of this reference/batch: based on the conclusion derived from investigation, it is not required to make actions in distributed product.Anyway, you will receive a credit note for one box of product for the units sent for analysis.No corrective/preventive actions needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTILENE 4/0 (1,5) 90CM 2XHR17 CV RCP
Type of Device
CARDIAC SUTURE
Manufacturer (Section D)
B.BRAUN SURGICAL SA
121 carretera de terrassa
rubi, 08191
SP  08191
MDR Report Key9349597
MDR Text Key172450819
Report Number3003639970-2019-00798
Device Sequence Number1
Product Code GAW
Combination Product (y/n)N
PMA/PMN Number
SEE H10
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/20/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberC3090902
Device Catalogue NumberC3090902
Device Lot Number118307
Was Device Available for Evaluation? No
Date Manufacturer Received01/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-